Chronic illness can be infuriatingly subtle, unpredictable, and impossible for anyone else to see. Eventually, after many ...

There are certain phrases that Wachuka Gichohi finds difficult to hear after enduring four years of living with long COVID, ...

No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...

Primary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...

XFOR READ THE FULL XFOR RESEARCH REPORT Business Update Positive Results from Six-Month Phase 2 Trial of Mavorixafor in ...

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...

Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor ...

REM stands for rapid eye movement — a stage in the sleep cycle when your brain is almost as active as when you’re awake.

Australia's COVID-19 response saved countless lives, but it also left hundreds of people believing they were suffering a constellation of strange symptoms from the vaccines. Now they're fighting a ...

Inovio Pharmaceuticals (NASDAQ: INO) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the electroCore Third Quarter 2024 ...